23.43USD-0.00%Mkt Cap: 151.41M USDP/E: —Last update: 2026-06-01
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate t…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap151.41M USD
Enterprise Value120.22M USD
Revenue (TTM)102.16M USD
Gross Profit83.33M USD
Net Income (TTM)-30.38M USD
Revenue/Share15.92 USD
Last Price23.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees53
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINLU1953136287
Valuation
P/E (Trailing)—
P/E (Forward)9.09
PEG0.89
EV/EBITDA31.41
EV/Revenue1.18
P/S1.48
P/B2.00
EPS (TTM)-5.55
EPS (Forward)2.58
52W Range
8.610100% of range23.46
52W High23.46 USD
52W Low8.610 USD
Profitability
Gross Margin70.19%
Oper. Margin-185.95%
EBITDA Margin3.75%
Profit Margin-25.59%
ROE-32.33%
ROA-11.38%
Growth
Revenue Growth-62.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.18M USD
CapEx (TTM)—
FCF Margin7.59%
FCF Yield5.12%
Net Debt-31.26M USD
Net Debt/EBITDA-8.17
Balance Sheet
Debt/Equity0.43
Current Ratio1.82
Quick Ratio1.45
Book Value/Sh11.73 USD
Cash/Share11.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateDec 26, 2025
Analyst Consensus
Rating—
Target (Mean)24.43 USD
Target Range21.80 USD – 28.00 USD
# Analysts3
Ownership
Shares Out.6.46M
Float5.57M
Insiders1.97%
Institutions39.94%
Short Interest
Short Ratio0.6d
Short % Float3.91%
Short % Out.3.86%
Shares Short249.30K
Short (prev mo.)287.24K
Technical
SMA 5019.64 (+19.3%)
SMA 20013.76 (+70.3%)
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)388.65K
Avg Vol (10d)336.38K
Technical Indicators
RSI (14)85.6
MACD1.2270
MACD Signal1.3823
MACD Hist.-0.1552
BB Upper25.06 USD
BB Middle22.74 USD
BB Lower20.42 USD
BB Width20.40%
ATR (14)0.2766 USD
Vol Ratio (20d)0.09x